Evidence map›Paper›PMID 33082762›Full record

ArticleCase reports in oncology

Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders, Diffuse Large B-Cell Lymphoma Type, in a Patient with Behçet's Disease Treated with Cyclosporine A.

Yuka Urano, Rintaro Ohe, Akane Yamada, Takanobu Kabasawa, Kazushi Suzuki, Takumi Kitaoka, Nobuyuki Tamazawa, Naing Ye Aung, Aya Utsunomiya, Tomomi Toubai and 1 more

Abstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuka UranoDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Rintaro OheDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Akane YamadaDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Takanobu KabasawaDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Kazushi SuzukiDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Takumi KitaokaDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Nobuyuki TamazawaDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Naing Ye AungDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Aya UtsunomiyaDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Tomomi ToubaiDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Kenichi IshizawaDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 40-year-old man had been treated for Behçet's disease (BD) with cyclosporine A (CsA) for 14 years. He presented multiple lymphadenopathies with fever. Histological examination of surgical biopsy showed other iatrogenic immunodeficiency-associated lymphoproliferative disorders, diffuse large B-cell lymphoma type with positivity for Epstein-Barr virus encoding RNA-1 (EBER-1).

Indexed as

Behçet's diseaseCyclosporine ADiffuse large B-cell lymphomaEpstein-Barr virusLymph node

Identifiers

PMID33082762
PMCPMC7548881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.